Abstract:
This study sought to investigate the effects of moringa leaves on some critical enzymes
[angiotensin-1 converting enzyme (ACE), acetylcholinesterase (AChE), arginase, monoamine
oxidase (MAO), phosphodiesterase-5 (PDE-5)] relevant to hypertension and antioxidant status in
vitro and in vivo. The antioxidant properties of the extracts were evaluated through (ABTS*,
DPPH* and OH*) radical scavenging, metal chelating (Fe 2+ ) and inhibition of Fe 2+ and sodium
nitroprusside (SNP) induced lipid peroxidation heart in vitro. The results revealed that the extracts
of the leaves and seeds both inhibited arginase (IC 50 leaves = 0.77mg/ml; seeds = 1.29mg/ml),
AChE (IC 50 leaves = 1.40mg/ml; seeds = 5.41mg/ml) and monoamine oxidase (IC 50 leaves =
0.65mg/ml; seeds = 0.90mg/ml) activity in concentration dependent manner. However, the leaves
exhibited a higher inhibitory effect than the seeds. Furthermore, the extract of the leaves had a
higher radical scavenging ability, [DPPH* (IC 50 leaves = 0.40mg/ml; seeds = 0.88mg/ml),
OH*(IC 50 leaves = 0.31mg/ml; seeds = 0.51mg/ml), Fe 2+ chelating ability (IC 50 leaves = 0.46mg/ml;
seeds = 0.93mg/ml) than the seed. The extract of the plant parts also inhibited SNP and Fe 2+
induced lipid peroxidation in heart, in vitro. Hypertensive rats (HYP) were placed on a dietary
regimen containing 2% and 4% moringa leaves and seeds. The result revealed that there was a
significant increase (p < 0.05) in the average weight changes of HYP in comparison to the normal
rat group. Also, there was a significant reduction (p < 0.05) in the blood pressure measurement
(systolic and diastolic) in the HYP treated groups compared to the HYP. However, there was no
significant difference (p > 0.05) in the blood pressure measurements of the normal control group
and the normal groups that were fed 2% and 4% moringa leaves and seeds supplemented diet. In
addition, there were significant reductions (p < 0.05) in the activities of arginase, AChE, PDE-5
and ACE of HYP rats treated with 2% and 4% moringa seed and leaves supplemented diet when
compared to the HYP group. Also, treatment with 2% and 4% moringa seed and leaves
significantly (p < 0.05) elevated the levels of antioxidant status (superoxide dismutase,
glutathione-s-transferase, reduced glutathione and catalase) in HYP rats fed diet supplemented
with 2% and 4% moringa seed and leaves compared to the HYP. Thus, the antioxidant effects and
inhibition of the key enzymes of the leaves and seeds could be part of the possible biochemical
mechanisms behind their folkloric use as antihypertensive plants. However, moringa leaves
showed higher antihypertensive effects than the seeds.